Suchergebnisse - "Whitaker, Heather J"

PubPharm (51)

1

Influenza vaccination during the 2021/22 season : A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients

enthalten in: Vaccine | 2024

von Whitaker, H. | Hassell, K. | Hoschler, K. | +15

2

Erratum to "Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England : A self-controlled case series analysis" [Vaccine: X 15 (2023) 100418

enthalten in: Vaccine: X | 2024

von Stowe, J. | Whitaker, H. | Andrews, N. | +1

ErratumFor: Vaccine X. 2023 Dec 01;15:100418. - PMID 38090643

3

Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England : A self-controlled case series analysis

enthalten in: Vaccine: X | 2023

von Stowe, J. | Whitaker, H. | Andrews, N. | +1

ErratumIn: Vaccine X. 2024 Jan 31;16:100449. - PMID 38322609

4

COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period : English primary care network cohort study

enthalten in: The Journal of infection | 2023

von Whitaker, H. | Tsang, R. | Byford, R. | +27

5

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection : A self-controlled case series analysis in England

enthalten in: PLoS medicine | 2023

von Stowe, J. | Miller, E. | Andrews, N. | +1

6

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers

enthalten in: bioRxiv.org | 2022

von Harris, R. | Whitaker, H. | Andrews, N. | +16

7

Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients

enthalten in: Transplantation | 2022

von Williams, S. | Whitaker, H. | Mumford, L. | +8

8

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England

enthalten in: bioRxiv.org | 2022

von Westrop, S. | Whitaker, H. | Powell, A. | +9

9

Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

enthalten in: The Journal of infection | 2022

von Whitaker, H. | Tsang, R. | Byford, R. | +22

10

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England

enthalten in: The Journal of infection | 2022

von Westrop, S. | Whitaker, H. | Powell, A. | +9

1
2
3
4
5
6
Nächster »
[6]